CANTON - MMS Holdings, a data-focused contract research organization – announced its partnership with the Institute for Advanced Clinical Trials to accelerate the development of life-saving therapeutics, including vaccines, medicines, and medical devices for children. MMS is a sponsor of I-ACT’s Spin Challenge, a creative way to raise funds to advance and accelerate children’s clinical
CANTON - TrialAssure has announced the release of TrialAssure LINK software for the efficient development, review, translation and publishing of plain language, or lay summaries. TrialAssure LINK transforms information from existing sources and auto-populates a majority of mandatory sections, generating lay summary language ready for review and editing. TrialAssure LINK will cut more than four weeks
LANSING - The Marijuana Regulatory Agency has issued a $20 million RFP for a non-profit organization or academic institution to provide one or more clinical trials that are approved by the United States food and drug administration to test the efficacy of marijuana in treating the medical conditions of United States armed services veterans and
NEW YORK - Pfizer and its German partner BioNTech SE gave the world an early Christmas present when they announced initial clinical studies show a COVID-19 vaccine was 90 percent effective. What’s more, in a press release, the companies said based on current projections the pharma companies expect to produce globally up to 50 million
ANN ARBOR — Esperion Therapeutics Inc. Monday announced the start of a Phase 3 study to assess the safety and efficacy of a combination pill containing its cholesterol-fighter, bempedoic acid, with ezetimibe, a drug that decreases cholesterol absorption in the small intestine. Ezetimibe is used when other cholesterol-lowering medications, such as statins, are not tolerated
